394 related articles for article (PubMed ID: 26874258)
1. Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium.
Choi ES; Oh AY; Seo KS; Hwang JW; Ryu JH; Koo BW; Kim BG
Anaesthesia; 2016 Apr; 71(4):443-9. PubMed ID: 26874258
[TBL] [Abstract][Full Text] [Related]
2. [Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial].
Barrio J; San Miguel G; García V; Pelegrín F
Rev Esp Anestesiol Reanim; 2007; 54(7):399-404. PubMed ID: 17953333
[TBL] [Abstract][Full Text] [Related]
3. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.
Hristovska AM; Duch P; Allingstrup M; Afshari A
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012763. PubMed ID: 28806470
[TBL] [Abstract][Full Text] [Related]
5. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
Naguib M; Riad W
Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium.
Carroll MT; Mirakhur RK; Lowry D; Glover P; Kerr CJ
Anaesthesia; 1998 Aug; 53(8):744-8. PubMed ID: 9797517
[TBL] [Abstract][Full Text] [Related]
7. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion.
Mellinghoff H; Radbruch L; Diefenbach C; Buzello W
Anesth Analg; 1996 Nov; 83(5):1072-5. PubMed ID: 8895288
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine.
Fuchs-Buder T; Meistelman C; Alla F; Grandjean A; Wuthrich Y; Donati F
Anesthesiology; 2010 Jan; 112(1):34-40. PubMed ID: 19952724
[TBL] [Abstract][Full Text] [Related]
9. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure.
Della Rocca G; Pompei L; Coccia C; Costa MG; Cecchini V; Vilardi V; Pietropaoli P
Minerva Anestesiol; 2003; 69(7-8):605-11, 612, 5. PubMed ID: 14564242
[TBL] [Abstract][Full Text] [Related]
10. Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium.
Suzuki T; Lien CA; Belmont MR; Tjan J; Savarese JJ
Can J Anaesth; 2003 Nov; 50(9):879-85. PubMed ID: 14617582
[TBL] [Abstract][Full Text] [Related]
11. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.
Abdulatif M; Mowafi H; al-Ghamdi A; el-Sanabary M
Br J Anaesth; 1996 Dec; 77(6):710-5. PubMed ID: 9014620
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of cisatracurium and rocuronium block at a tactile train-of-four count of 2: should quantitative assessment of neuromuscular function be mandatory?
Kopman AF; Zank LM; Ng J; Neuman GG
Anesth Analg; 2004 Jan; 98(1):102-106. PubMed ID: 14693596
[TBL] [Abstract][Full Text] [Related]
13. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†,
Kaufhold N; Schaller SJ; Stäuble CG; Baumüller E; Ulm K; Blobner M; Fink H
Br J Anaesth; 2016 Feb; 116(2):233-40. PubMed ID: 26787792
[TBL] [Abstract][Full Text] [Related]
14. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function.
Kopman AF; Kopman DJ; Ng J; Zank LM
J Clin Anesth; 2005 Feb; 17(1):30-5. PubMed ID: 15721727
[TBL] [Abstract][Full Text] [Related]
16. Neostigmine injected 5 minutes after low-dose rocuronium accelerates the recovery of neuromuscular function.
Lederer W; Reiner T; Khuenl-Brady KS
J Clin Anesth; 2010 Sep; 22(6):420-4. PubMed ID: 20868962
[TBL] [Abstract][Full Text] [Related]
17. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
18. Neuromuscular blocking effects of cisatracurium and its antagonism with neostigmine in a canine model of autosomal-recessive centronuclear myopathy.
Martin-Flores M; Paré MD; Campoy L; Gleed RD
Br J Anaesth; 2015 Dec; 115(6):927-31. PubMed ID: 26582854
[TBL] [Abstract][Full Text] [Related]
19. Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium.
Maybauer DM; Geldner G; Blobner M; Pühringer F; Hofmockel R; Rex C; Wulf HF; Eberhart L; Arndt C; Eikermann M
Anaesthesia; 2007 Jan; 62(1):12-7. PubMed ID: 17156221
[TBL] [Abstract][Full Text] [Related]
20. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
Jones RK; Caldwell JE; Brull SJ; Soto RG
Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
